NEW
YORK, Aug. 5, 2024 /PRNewswire/ -- The Gross Law
Firm issues the following notice to shareholders of MacroGenics,
Inc. (NASDAQ: MGNX).
Shareholders who purchased shares of MGNX during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/macrogenics-inc-loss-submission-form-2/?id=93533&from=4
CLASS PERIOD: March 7, 2024
to May 9, 2024
ALLEGATIONS: During the class period, Defendants made
material misrepresentations about the safety data from its TAMARACK
Phase 2 study of vobramitamab duocarmazine. On May 9, 2024, the investing public learned that
the drug was significantly more dangerous than defendants had
previously represented. Following this news, MGNX's stock declined
77.4% due to a drop of $11.36/share.
DEADLINE: September 24,
2024 Shareholders should not delay in registering for
this class action. Register your information here:
https://securitiesclasslaw.com/securities/macrogenics-inc-loss-submission-form-2/?id=93533&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of MGNX during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is September 24, 2024. There is no
cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross
Law Firm is committed to ensuring that companies adhere to
responsible business practices and engage in good corporate
citizenship. The firm seeks recovery on behalf of investors who
incurred losses when false and/or misleading statements or the
omission of material information by a company lead to artificial
inflation of the company's stock. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content to download
multimedia:https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-macrogenics-incmgnx-urged-to-join-class-action--contact-the-gross-law-firm-to-learn-more-302213753.html
SOURCE The Gross Law Firm